Healthequity Inc (HQY) is now in the Undervalued zone, suggesting that its current forward PE ratio of 22.01 is considered Undervalued compared with the five-year average of 34.40. The fair price of Healthequity Inc (HQY) is between 82.06 to 148.54 according to relative valuation method. Compared to the current price of 77.88 USD , Healthequity Inc By Undervalued By 5.09%.

Relative Value

Fair Zone

82.06-148.54

Current Price：77.88

5.09%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Healthequity Inc (HQY) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Healthequity Inc (HQY) has a current Price-to-Book (P/B) ratio of 0.00. Compared to its 3-year average P/B ratio of 3.41, the current P/B ratio is approximately -100.00% higher. Relative to its 5-year average P/B ratio of 3.23, the current P/B ratio is about -100.00% higher. Healthequity Inc (HQY) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 3.91%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 3.41%, the current FCF yield is about -100.00% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for HQY competitors is 6.78, providing a benchmark for relative valuation. Healthequity Inc Corp (HQY.O) exhibits a P/S ratio of 6.78, which is 0% above the industry average. Given its robust revenue growth of 7.23%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of HQY increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of HQY in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is HQY currently overvalued or undervalued?

What is Healthequity Inc (HQY) fair value?

HQY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Healthequity Inc (HQY) is between 82.06 to 148.54 according to relative valuation method.

How does HQY's valuation metrics compare to the industry average?

The average P/S ratio for HQY's competitors is 6.78, providing a benchmark for relative valuation. Healthequity Inc Corp (HQY) exhibits a P/S ratio of 6.78, which is 0.00% above the industry average. Given its robust revenue growth of 7.23%, this premium appears unsustainable.

What is the current P/B ratio for Healthequity Inc (HQY) as of Mar 02 2026?

As of Mar 02 2026, Healthequity Inc (HQY) has a P/B ratio of 0.00. This indicates that the market values HQY at 0.00 times its book value.

What is the current FCF Yield for Healthequity Inc (HQY) as of Mar 02 2026?

As of Mar 02 2026, Healthequity Inc (HQY) has a FCF Yield of 0.00%. This means that for every dollar of Healthequity Inc's market capitalization, the company generates 0.00 cents in free cash flow.

What is the current Forward P/E ratio for Healthequity Inc (HQY) as of Mar 02 2026?

As of Mar 02 2026, Healthequity Inc (HQY) has a Forward P/E ratio of 22.01. This means the market is willing to pay $22.01 for every dollar of Healthequity Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Healthequity Inc (HQY) as of Mar 02 2026?

As of Mar 02 2026, Healthequity Inc (HQY) has a Forward P/S ratio of 6.78. This means the market is valuing HQY at $6.78 for every dollar of expected revenue over the next 12 months.

HQY Valuation